Autres langues PeptiDream Inc.

Actions

4587

JP3836750004

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 16/05/2024			Varia. 5j.	Varia. 1 janv.
1 900 ^JPY	-2,56%		-3,82%	+27,78%

30/04	Bourse Zurich: les indices terminent en rouge à la veille de la Fed	AW
30/04	Novartis étend sa collaboration avec le japonais Peptidream	AW

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Novartis stärkt Radioligand-Pipeline mit Übernahme	02/05
Novartis baut Zusammenarbeit mit japanischer PeptiDream in Krebsforschung aus	30/04
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis	30/04
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	30/04
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	30/04
Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares	15/02
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	14/02
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors	22/12
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	09/11
PeptiDream : Corporate Presentation（November 2023, English version)(2MB)	01/11
PeptiDream : コーポレート・プレゼンテーション(2023年11月、英語版）(2MB)	01/11
PeptiDream and Bristol-Myers Squibb to Explore Alternatives as PDL1 Program Faces Setback	27/10/23
Peptidream Announces Update on PDL1 Program Partnered with Bristol-Myers Squibb Company	26/10/23
PeptiDream : Sustainability Report 2023(2.9 MB)	27/09/23
PeptiDream Announces Initial Public Offering of RayzeBio and Update on GPC3 Program	20/09/23
PeptiDream Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide-Radioisotope Drug Conjugates	20/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PeptiDream Inc.

Actions

4587

JP3836750004

Autres langues

Filtres